Matinas Biopharma (6LJ0.F) Q2 2026 Earnings

7MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Next
-0.69
-0.36
-0.02
0.31

Details

Expected EPS
N/A
Actual EPS
N/A
Surprise EPS
0
Surprise Percent
+NaN%

Description

Matinas Biopharma (6LJ0.F) will report earnings of for Q2 2026 on May 07, 2026.

0 Comments

Share your thoughts